Margot E Cohen1, Hojjat Salmasian2, Jianhua Li2, Jianfang Liu3, Philip Zachariah4, Jason D Wright5, Daniel E Freedberg6. 1. Department of Medicine, Columbia University Medical Center, New York, NY. 2. Biomedical Informatics, New York-Presbyterian Hospital, New York, NY. 3. School of Nursing, Columbia University, New York, NY. 4. Department of Pediatrics, Columbia University Medical Center, New York, NY. 5. Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY. 6. Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, NY. Electronic address: def2004@cumc.columbia.edu.
Abstract
BACKGROUND: Antibiotic-resistant infections have high rates of morbidity and mortality, and exposure to antibiotics is the crucial risk factor for development of antibiotic resistance. If surgical antibiotic prophylaxis (SAP) increases risk for antibiotic-resistant infections, prophylaxis may cause net harm, even if it decreases overall infection rates. STUDY DESIGN: This retrospective cohort study included adults who underwent elective surgical procedures and developed infections within 30 postoperative days. Procedures from multiple disciplines were included if SAP was considered discretionary by current guidelines. Postoperative antibiotic-resistant infections were defined as positive culture results from any site within 30 postoperative days, showing intermediate or nonsusceptibility across 1 or more antibiotic classes. Surgical antibiotic prophylaxis included use of antibiotics within any class and at any dose from 1 hour before first incision until the end of the operation. RESULTS: Among 689 adults with postoperative infections, 338 (49%) had postoperative resistant infections. Use of SAP was not associated with postoperative antibiotic-resistant infections (odds ratio [OR] 0.99; 95% CI 0.67 to 1.46). This result remained robust when the SAP definition was extended to antibiotics given within 4 hours before first incision (OR 0.94; 95% CI 0.63 to 1.40) and when the follow-up window was narrowed to 14 days (OR 0.82; 95% CI 0.50 to 1.34). Previous antibiotic-resistant infections were associated with risk for postoperative antibiotic-resistant infections (OR 1.81; 95% CI 1.16 to 2.83). CONCLUSIONS: Use of SAP was not associated with risk for postoperative antibiotic-resistant infections in a large cohort of patients with postoperative infections. This provides important reassurance regarding use of surgical antibiotic prophylaxis.
BACKGROUND: Antibiotic-resistant infections have high rates of morbidity and mortality, and exposure to antibiotics is the crucial risk factor for development of antibiotic resistance. If surgical antibiotic prophylaxis (SAP) increases risk for antibiotic-resistant infections, prophylaxis may cause net harm, even if it decreases overall infection rates. STUDY DESIGN: This retrospective cohort study included adults who underwent elective surgical procedures and developed infections within 30 postoperative days. Procedures from multiple disciplines were included if SAP was considered discretionary by current guidelines. Postoperative antibiotic-resistant infections were defined as positive culture results from any site within 30 postoperative days, showing intermediate or nonsusceptibility across 1 or more antibiotic classes. Surgical antibiotic prophylaxis included use of antibiotics within any class and at any dose from 1 hour before first incision until the end of the operation. RESULTS: Among 689 adults with postoperative infections, 338 (49%) had postoperative resistant infections. Use of SAP was not associated with postoperative antibiotic-resistant infections (odds ratio [OR] 0.99; 95% CI 0.67 to 1.46). This result remained robust when the SAP definition was extended to antibiotics given within 4 hours before first incision (OR 0.94; 95% CI 0.63 to 1.40) and when the follow-up window was narrowed to 14 days (OR 0.82; 95% CI 0.50 to 1.34). Previous antibiotic-resistant infections were associated with risk for postoperative antibiotic-resistant infections (OR 1.81; 95% CI 1.16 to 2.83). CONCLUSIONS: Use of SAP was not associated with risk for postoperative antibiotic-resistant infections in a large cohort of patients with postoperative infections. This provides important reassurance regarding use of surgical antibiotic prophylaxis.
Authors: Maxim G Bloomfield; Matthew J Page; Alice G McLachlan; Rodney C Studd; Timothy K Blackmore Journal: J Urol Date: 2017-03-10 Impact factor: 7.450
Authors: Walter P Weber; Edin Mujagic; Marcel Zwahlen; Marcel Bundi; Henry Hoffmann; Savas D Soysal; Marko Kraljević; Tarik Delko; Marco von Strauss; Lukas Iselin; Richard X Sousa Da Silva; Jasmin Zeindler; Rachel Rosenthal; Heidi Misteli; Christoph Kindler; Peter Müller; Ramon Saccilotto; Andrea Kopp Lugli; Mark Kaufmann; Lorenz Gürke; Urs von Holzen; Daniel Oertli; Evelin Bucheli-Laffer; Julia Landin; Andreas F Widmer; Christoph A Fux; Walter R Marti Journal: Lancet Infect Dis Date: 2017-04-03 Impact factor: 25.071
Authors: Brian G Bell; Francois Schellevis; Ellen Stobberingh; Herman Goossens; Mike Pringle Journal: BMC Infect Dis Date: 2014-01-09 Impact factor: 3.090
Authors: Egija Zaura; Bernd W Brandt; M Joost Teixeira de Mattos; Mark J Buijs; Martien P M Caspers; Mamun-Ur Rashid; Andrej Weintraub; Carl Erik Nord; Ann Savell; Yanmin Hu; Antony R Coates; Mike Hubank; David A Spratt; Michael Wilson; Bart J F Keijser; Wim Crielaard Journal: MBio Date: 2015-11-10 Impact factor: 7.867
Authors: Gary Duclos; Bruno Pastene; Fanny Depeyre; Zoé Meresse; Nadim Cassir; Ignacio Martin-Loeches; Sharon Einav; Laurent Zieleskiewicz; Marc Leone Journal: Ann Transl Med Date: 2018-10
Authors: Bradley D Menz; Esmita Charani; David L Gordon; Andrew J M Leather; S Ramani Moonesinghe; Cameron J Phillips Journal: Infect Drug Resist Date: 2021-12-07 Impact factor: 4.003